Marina Boccardi

6.3k total citations
65 papers, 1.9k citations indexed

About

Marina Boccardi is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marina Boccardi has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Psychiatry and Mental health, 28 papers in Physiology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marina Boccardi's work include Dementia and Cognitive Impairment Research (41 papers), Alzheimer's disease research and treatments (27 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Marina Boccardi is often cited by papers focused on Dementia and Cognitive Impairment Research (41 papers), Alzheimer's disease research and treatments (27 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Marina Boccardi collaborates with scholars based in Italy, Switzerland and United States. Marina Boccardi's co-authors include Giovanni B. Frisoni, Flavio Nobili, Alexander Drzezga, Zuzana Walker, Peter J. Nestor, Federica Agosta, Javier Arbizu, Femke H. Bouwman, Valentina Garibotto and Cristina Festari and has published in prestigious journals such as Neurology, Journal of Affective Disorders and Neurobiology of Aging.

In The Last Decade

Marina Boccardi

63 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Boccardi Italy	27	1.0k	760	450	399	293	65	1.9k
Anupa Arora United States	11	1.1k 1.1×	1.1k 1.4×	442 1.0×	390 1.0×	153 0.5×	19	1.6k
Daniele Altomare Switzerland	18	725 0.7×	694 0.9×	376 0.8×	330 0.8×	203 0.7×	52	1.7k
Panagiotis Alexopoulos Germany	29	1.2k 1.2×	945 1.2×	522 1.2×	340 0.9×	242 0.8×	110	2.6k
Sander C.J. Verfaillie Netherlands	26	1.1k 1.1×	1.0k 1.3×	536 1.2×	451 1.1×	186 0.6×	59	1.9k
Marissa D. Zwan Netherlands	26	1.3k 1.2×	1.1k 1.4×	315 0.7×	221 0.6×	138 0.5×	71	1.8k
Stéphane Epelbaum France	24	903 0.9×	818 1.1×	646 1.4×	265 0.7×	214 0.7×	67	2.2k
Nicolas Villain France	19	1.2k 1.2×	1.3k 1.7×	880 2.0×	481 1.2×	282 1.0×	68	2.7k
Colin Groot Netherlands	21	897 0.9×	681 0.9×	444 1.0×	153 0.4×	177 0.6×	49	1.7k
Sylvia Villeneuve Canada	27	1.1k 1.0×	1.0k 1.3×	570 1.3×	340 0.9×	175 0.6×	102	2.2k
Robert Laforce Canada	26	1.1k 1.1×	717 0.9×	1.1k 2.5×	229 0.6×	417 1.4×	117	2.6k

Countries citing papers authored by Marina Boccardi

Since Specialization

Citations

This map shows the geographic impact of Marina Boccardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Boccardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Boccardi more than expected).

Fields of papers citing papers by Marina Boccardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Boccardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Boccardi. The network helps show where Marina Boccardi may publish in the future.

Co-authorship network of co-authors of Marina Boccardi

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Boccardi. A scholar is included among the top collaborators of Marina Boccardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Boccardi. Marina Boccardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiotis, Konstantinos, Alessandra Dodich, Marina Boccardi, et al.. (2021). Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. 48(7). 2086–2096. 10 indexed citations

Wolters, Emma E., Alessandra Dodich, Marina Boccardi, et al.. (2021). Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework. European Journal of Nuclear Medicine and Molecular Imaging. 48(7). 2097–2109. 29 indexed citations

Khlif, Mohamed Salah, Emilio Werden, Natalia Egorova, et al.. (2019). Assessment of longitudinal hippocampal atrophy in the first year after ischemic stroke using automatic segmentation techniques. NeuroImage Clinical. 24. 102008–102008. 18 indexed citations

Drzezga, Alexander, Daniele Altomare, Cristina Festari, et al.. (2018). Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 45(9). 1487–1496. 35 indexed citations

Agosta, Federica, Daniele Altomare, Cristina Festari, et al.. (2018). Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 45(9). 1546–1556. 22 indexed citations

Nestor, Peter J., Daniele Altomare, Cristina Festari, et al.. (2018). Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. European Journal of Nuclear Medicine and Molecular Imaging. 45(9). 1509–1525. 79 indexed citations

Walker, Zuzana, Federica Gandolfo, Stefania Orini, et al.. (2018). Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia. European Journal of Nuclear Medicine and Molecular Imaging. 45(9). 1534–1545. 78 indexed citations

Nobili, Flavio, Cristina Festari, Daniele Altomare, et al.. (2018). Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders. European Journal of Nuclear Medicine and Molecular Imaging. 45(9). 1557–1566. 34 indexed citations

Garibotto, Valentina, Karl Herholz, Marina Boccardi, et al.. (2017). Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52. 183–195. 59 indexed citations

10.

Chiotis, Konstantinos, Laure Saint‐Aubert, Marina Boccardi, et al.. (2017). Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52. 214–227. 48 indexed citations

11.

Porteri, Corinna, Emiliano Albanese, Charles Scerri, et al.. (2017). The biomarker-based diagnosis of Alzheimer's disease. 1—ethical and societal issues. Neurobiology of Aging. 52. 132–140. 43 indexed citations

12.

Cerami, Chiara, Bruno Dubois, Marina Boccardi, et al.. (2017). Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52. 153–166. 42 indexed citations

13.

Boccardi, Marina, Martina Bocchetta, Félix C. Morency, et al.. (2015). Training labels for hippocampal segmentation based on the EADC‐ADNI harmonized hippocampal protocol. Alzheimer s & Dementia. 11(2). 175–183. 92 indexed citations

14.

Boccardi, Marina, Daniele Altomare, Clarissa Ferrari, et al.. (2015). Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic?. Neurodegenerative Diseases. 16(1-2). 111–117. 3 indexed citations

15.

Preti, Antonio, Cristina Muscio, Marina Boccardi, et al.. (2014). Impact of alcohol consumption in healthy adults: A magnetic resonance imaging investigation. Psychiatry Research Neuroimaging. 224(2). 96–103. 8 indexed citations

16.

Boccardi, Marina, Lorena Bresciani, Anna Caroli, et al.. (2009). Clinical and medial temporal features in a family with mood disorders. Neuroscience Letters. 468(2). 93–97. 18 indexed citations

17.

Pennanen, Corina, Cristina Testa, Marina Boccardi, et al.. (2006). The Effect of Apolipoprotein Polymorphism on Brain in Mild Cognitive Impairment: A Voxel-Based Morphometric Study. Dementia and Geriatric Cognitive Disorders. 22(1). 60–66. 15 indexed citations

18.

Boccardi, Marina & Giovanni B. Frisoni. (2005). Cognitive rehabilitation for severe dementia: Critical observations for better use of existing knowledge. Mechanisms of Ageing and Development. 127(2). 166–172. 17 indexed citations

19.

Boccardi, Marina, Francesca Sabattoli, Mikko P. Laakso, et al.. (2004). Frontotemporal dementia as a neural system disease. Neurobiology of Aging. 26(1). 37–44. 110 indexed citations

20.

Boccardi, Marina & Stefano F. Cappa. (1997). Valori normativi di produzione categoriale per la lingua italiana. Giornale italiano di psicologia. 24(2). 425–438. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact